About
Lexeo Therapeutics is developing gene therapy treatments targeting genetically mediated cardiovascular diseases and APOE4-associated Alzheimer's disease, advancing genetic medicine with a focus on efficient development and advanced manufacturing.
Explore Lexeo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.